(Q81310348)
Statements
Phase I trial of MS-275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies (English)
Shivaani Kummar
Martin Gutierrez
Erin R Gardner
Erin Donovan
Kyunghwa Hwang
Eun Joo Chung
Min-Jung Lee
Kim Maynard
Mikhail Kalnitskiy
Alice Chen
Giovanni Melillo
Qin C Ryan
Barbara Conley
William D Figg
James Zwiebel
James H Doroshow